Comparison of treatment outcomes between biliary plastic stent placements with and without endoscopic sphincterotomy for inoperable malignant common bile duct obstruction.
OBJECTIVE
Considerable controversy surrounds the adoption of endoscopic sphincterotomy (ES) to facilitate the placement of 10F plastic stents (PS) and to reduce the risk of pancreatitis The aim of the study was to assess the possible advantages of ES before PS placement.


METHODS
From 3/1996 to 6/2001, 172 consecutive patients, who underwent placement of a single 10F- polyethylene stent for inoperable malignant strictures of the common bile duct, were randomly assigned to 2 groups. In group A (96 patients), a ES was performed before PS placement In Group B, 96 patients had PS directly. Early complications (within 30 d) and late effects (from 30 d to stent replacement) were assessed. Patency interval was defined as the period between PS placement and obstruction or death. The success of stent replacement in the 2 groups was evaluated.


RESULTS
Stent insertion was successful in 95.8%(92/96) of the pts in group A and in 93.7%(90/96) of the patients in group B (P>0.05). Early complications were more frequent in patients who underwent ES (6.5% vs 4.4%) but the data were not significant (P>0.05). In group A pancreatitis developed in two patients and bleeding in three; whereas pancreatitis occurred in 2 patients in group B. Complications were managed conservatively. No procedure related mortality occurred. All late complications were acute cholangitis due to stent occlusion. We performed a stent replacement in 87 patients that was successful in 84 cases without differences between groups.


CONCLUSIONS
Sphincterotomy does not seem to be necessary for placement of 10F-PS in patients with malignant common bile duct obstruction.
Giorgio
Pietro Di
PD
Department of Gastroenterology, Pellegrini Hospital, Napoli, Italy. digiorgiop@hotmail.com
Luca
Leonardo De
LD
D000368:Aged; D000369:Aged, 80 and over; D018281:Cholangiocarcinoma / Q000150:complications* / Q000556:secondary / Q000601:surgery; D001651:Cholestasis, Extrahepatic / Q000209:etiology / Q000601:surgery*; D016099:Endoscopy, Gastrointestinal / Q000379:methods; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D010190:Pancreatic Neoplasms / Q000150:complications* / Q000556:secondary / Q000601:surgery; D010195:Pancreatitis / Q000453:epidemiology / Q000517:prevention & control; D010969:Plastics; D011183:Postoperative Complications / Q000453:epidemiology / Q000517:prevention & control; D040242:Risk Reduction Behavior; D009803:Sphincter of Oddi / Q000601:surgery*; D015607:Stents
D010969:Plastics